Yuan M, Zhou L, Li W, Du X, Weng J, Yang L, Ma Y, Liu B, Liu Z, Wen Q, Zhao S, Zhang Y, Bai Q, Feng X, Han Y, Liu C, Meng L, Wang B, Ran X, Wang X, Zhang H, Zeng Y, Leng Q, Yu L, Li Z, Gale RP, Huang X, Jiang Q. Olverembatinib in accelerated-phase chronic myeloid leukemia: efficacy and safety evaluation. Haematologica; https://doi.org/10.3324/haematol.2025.288249 [Early view].